1.Game Analysis of the Definition of "New Drugs"
China Pharmacy 2005;0(16):-
OBJECTIVE:To provide reference for definition and research & development of new drugs in China.METHODS:The history of the definition for new drugs was reviewed,and the effects of the definition of new drugs on the research and development of drugs were discussed by using the game theory "Tragedy of the Commons" and "Anti-Tragedy of the Commons".RESULTS & CONCLUSIONS:The definition of new drugs should be more and more scientific and reasonable and in line with the aim of building new creative country,meanwhile,efforts should be paid to avoid the above mentioned two kinds of tragedies.
2.Corticosteroid-induced severe glaucoma and posterior subcapsular cataract: a case report
International Eye Science 2009;9(9):1652-1654
Corticosteroid-induced glaucoma (CIG) is a form of open angle glaucoma associated with both topical and systemic administration of corticosteroids. Here we described the clinical findings in a patient with severe glaucoma and posterior subcapsular cataract (PSC) after topical administration of corticosteroid eye drops. We concluded corticosteroid eye drop was an effective medicine for inflammation of the eyes; however,prolonged use could cause severe vision loss as a result of intractable corticosteroid-induced glaucoma and cataract.
3.The treatment of hepatic carcinoma with B-ultrasonographic located radiofrequency ablation
Rong LI ; Fangxiong MEI ; Yonghong YE ;
Chinese Journal of Current Advances in General Surgery 1999;0(04):-
To study the value of the treatment of hepatocellular carcinoma with B ultrasonographic located radiofrequency ablation(RFA).Methods: The radiofrequency multielectrodes were inserted into the hepatic carcinoma with B ultrasonographic locating.RFA was applied with the power from 50W up to 90W. RFA scope was 1cm out of the margin of the tumor mass in three dimension. After RFA treatment, the AFP level changes and the B ultrasonography, computed tomography (CT), biopsy of the liver and hepato arterioangiography were observed.Results: One month after RFA treatment ,in those with abnormal AFP level AFP falled to normal in 18/20 patients, the volume of the tumor mass were enlarged in 9 patients, not changed in 8 patients and decreased in the others at CT and/or ultrasonography. The alive cancer cells in the margin of the tumor mass were found in 1/6 patients at biopsy. The scattering bloodstream in the carcinoma was showed in 1/8 patients on hepato arteriography. After three months, the volume of the tumor was remarkably decreased in 25 patients.Conclusion: The results suggests that RFA appears to ablate hepatic carcinoma effectively as suitable method mastered.
4.Treatment of unresectable large liver cancer by radiofrequency ablation with clustered electrodes
Fangxiong MEI ; Rong LI ; Yonghong YE
Chinese Journal of Minimally Invasive Surgery 2001;0(02):-
Objective To evaluate the clinical significance of radiofrequency ablation (RFA) with clustered electrodes in the treatment of unresectable large primary liver cancer. Methods Under the guidance of ultrasonography, Percutaneous and intraoperative RFA was performed in 38 patients and 5 patients,respectively. Additional ablation could be conducted if residual tumor or recurrence was found after the primary treatment. Results A total of 62 times of RFA, with a mean of 6 foci every treatment, were completed in the 43 patients, in whom the mean diameter of tumor was 7 3 cm. AFP levels had decreased to normal in 18/32 patients (56 3%) whose preoperative AFP levels were above 400 ?g/L. Postoperative CT examinations indicated that the tumor was completely ablated in 33/43 patients (76 7%). Frequent complications included fever, local pain, and liver impairment. No severe complications or treatment-related deaths were seen. The 1-year survival rate was 79 3% (23/29). Conclusions RFA with clustered electrodes in the treatment of unresectable large liver cancer can produce extensive coagulation necrosis of tumor, being a safe and effective therapeutic method. It is breaking fresh ground in the management of unresectable large
5.Experience of Clinical Pharmacists Participating in the Therapy for an Ovarian Cancer Patient Complicated with Cirrhosis
Wen WU ; Ye YE ; Li CHEN ; Zhen ZENG ; Mei JIN
China Pharmacist 2016;19(5):962-964
Objective:To improve the safety,rationality and efficacy of medication for ovarian cancer patients complicated with cirrhosis by the participation of clinical pharmacists in the therapy. Methods:Clinical pharmacists participated in the therapy for an ovarian cancer patient with cirrhosis,and provided a rational and individualized therapeutic regimen through the drug experience of clinical pharmacists as well as the relevant medical guides and literatures. Results:The therapeutic efficacy was increased by the participation of clinical pharmacists in the therapy,the potential risk of the chemotherapy was avoided and the security of medication was assured. Conclusion:The participation of clinical pharmacists in therapeutic practice can improve the normalization of pharmacotherapy for ovarian cancer patients with cirrhosis,which also can provide ideas and methods for treating the similar patients.
6.Effects of postpartum lactation of puerperal women with qi and blood deficiency treated by catgut embedding therapy.
Li-Ping LI ; Ye-Hua BAO ; Jia-Mei CHU
Chinese Acupuncture & Moxibustion 2014;34(2):189-190
Acupuncture Therapy
;
Adult
;
Catgut
;
utilization
;
Female
;
Humans
;
Lactation
;
Lactation Disorders
;
physiopathology
;
therapy
;
Postpartum Period
;
physiology
;
Qi
;
Young Adult
7.Study on Inhibitory Effect of Aqueous Extract of Taxus Chinensis var. mairei Combined Erlotnib on A549 Xenograft in Nude Mice and Its Mechanism.
Qing-li CUI ; Ping YE ; Qi-jin SHU ; Mei SHAO
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(5):572-577
OBJECTIVETo study the effect of aqueous extract of Taxus chinensis var. mairei (AETC) combined Erlotnib on the growth of A549 xenograft in nude mice and its mechanism.
METHODSThe xenograft model in nude mice was established by inoculating A549 cells subcutaneously. BALB/c nude mice bearing A549 xenograft were randomly divided into six groups, i.e., the low dose Erlotinib group (A) , the standard dose Erlotnib group (B) , the low dose Erlotinib combined AETC group (C), the standard dose Erlotnib combined AETC group (D), the AETC group (E), the control group (F), 12 in each group. Different medication was performed for 7 successive weeks after 24 h. One mL blood was withdrawn and tumor tissues taken. The tumor inhibition rate was calculated. The combined effect was analyzed by Jin's Formula [Q = Ea + b/(Ea + Eb-Ea x Eb) ]. mRNA and protein expression levels of epidermal growth factor receptor (EGFR), cyclooxygenase-2 (COX-2), and B cell lymphoma-2 (Bcl-2) in xenografts were detected using real-time RT-PCR and ELISA.
RESULTSCompared with Group F, the xenograft weight was obviously lowered in Group B-E (P < 0.05, P < 0.01). The q value was 0.92 in Group C and 0.96 in Group D, which was obtained by simple adding of the two drugs. Compared with Group F, EG- FR mRNA expression in Group D and E, COX-2 mRNA expression in Group A-E; Bcl-2 mRNA expression in Group B-D; COX-2 protein expression in Group B-E; Bcl-2 protein expression in Group C and D were obviously lowered with statistical difference (P < 0.05, P < 0.01).
CONCLUSIONSAETC combined low dose and standard dose Erlotinib had synergistic effect on tumor inhibition. Its mechanism might be associated with down-regulating mRNA and protein expression levels of COX-2 and Bcl-2.
Animals ; Antineoplastic Agents ; pharmacology ; Antineoplastic Combined Chemotherapy Protocols ; pharmacology ; Cell Line, Tumor ; Cyclooxygenase 2 ; metabolism ; Drugs, Chinese Herbal ; pharmacology ; Enzyme Inhibitors ; pharmacology ; Erlotinib Hydrochloride ; pharmacology ; Heterografts ; Lung Neoplasms ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Receptor, Epidermal Growth Factor ; metabolism ; Taxus ; Transplantation, Heterologous
9.Clinical study of gabapentin in the treatment of refractory uremic pruritus in hemodialysis patients
Lin LI ; Changlin MEI ; Lijun SUN ; Chaoyang YE
Chinese Journal of Nephrology 2010;26(5):335-338
Objective To assess the safety and efficacy of gabapentin in treatment of refractory uremic pruritus in maintenance hemodialysis (MHD)patients. Methods A randomized controlled trial was performed.Forty-nine MHD patients with severe pruritus were randomly divided into treatment group(gabapentin 100-300 mg at dialysis day before sleep)and the control group(loratadine 10 mg daily).The efficacy was assessed by visual analogue score,pruritus score and improved Duo's VAG Score after 12-week treatment,and the side effect was also observed to assess the safety. Results After treatment,the frequency,degree and area of pruritus in 25 patients of treatment group were significantly reduced,and VAS score(1.46±1.38vs 8.71±1.17,P<0.01),VAG score(2.92±1.63 vs 8.29±0.68,P<0.01)and the improved Duo's pruritus score(11.33±3.99 vs 30.75±4.87,P<0.01)decreased significantly compared with that of prior treatment.The symptoms of 24 patients in control group were improved partly,which were not as good as those in treatment group(P<0.01).The side effects of gabapentin were drowsiness and dizziness,but most symptoms were relieved or disappeared within 1 week and no patient interrupted therapy.No serious adverse events were observed. Conclusion Gabapentin is safe and effective for refractory uremic pruritus,but long-term efficacy and safety requires larger sample and long-term observation.
10.Clinical study on 27 children with Epstein-Barr virus encephalitis
hong, LI ; lu-mei, YE ; pei-jia, CHEN
Journal of Applied Clinical Pediatrics 2004;0(09):-
Objective To explore the clinical characteristics and diagnosis of Epstein-Barr(EB) virus encephalitis(EBE) in children. Methods The verification of EBE was based on detection of EBV DNA in cerebrospinal fluid (CSF) by fluorogenic quantitative PCR(FQ-PCR) and Nest-PCR. The clinical and CSF changes of 27 EBE cases and 26 controls were analyzed and compared. Results EB-DNA in CSF by FQ-PCR of 13 cases of EBE was (2.82?2.03)?10 3copies.There was no significant difference in clinical manifestations between EBE and HSE groups, except that WBC in CSF of EBE was lower than those of HSE.Conclusions EBE is not infrequent, about 10 % of encephalitis in children. EBE is always present independently, which is not a complication of infectious mononucleosis(IM).Detection of EBV-DNA in CSF is a sensitive and specific test for diagnosing of EBE. Early treatment may be beneficial to the prognosis of EBE.